HotOtc Featured Company: CardioVascular BioTherapeutics, Inc. (CVBT.OB) Solid Results in Phase I – Permission Granted for Phase II
CardioVascular BioTherapeutics’ lead heart disease medication has been granted Phase II testing permission after solid results were found in Phase…